Professor David Wheeler - Renoprotective effects of SGLT2 inhibitors

  Рет қаралды 2,240

At the Limits - Leading Medical Education

At the Limits - Leading Medical Education

Күн бұрын

Пікірлер: 1
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond
25:32
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond
At the Limits - Leading Medical Education
Рет қаралды 1,8 М.
Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits
26:50
Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits
At the Limits - Leading Medical Education
Рет қаралды 4,8 М.
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
DO$HIK
Рет қаралды 3,3 МЛН
“Don’t stop the chances.”
00:44
“Don’t stop the chances.”
ISSEI / いっせい
Рет қаралды 62 МЛН
Тренировка памяти 🧠 #boardgames #настольныеигры #умныеигры #игры #настолки #логическиеигры
00:49
Тренировка памяти 🧠 #boardgames #настольныеигры #умныеигры #игры #настолки #логическиеигры
Двое играют | Наташа и Вова
Рет қаралды 48 МЛН
☝️☝️☝️МАЛЫШ-СИЛАЧ 14 лет притворился НОВИЧКОМ | Школьник сделал то, чего не смог качок
00:50
☝️☝️☝️МАЛЫШ-СИЛАЧ 14 лет притворился НОВИЧКОМ | Школьник сделал то, чего не смог качок
Nikita Zdradovskiy
Рет қаралды 7 МЛН
The Four Pillars of Managing Diabetic Kidney Disease with Dr Brendon Neuen
40:42
The Four Pillars of Managing Diabetic Kidney Disease with Dr Brendon Neuen
Ottawa Nephrology
Рет қаралды 3,7 М.
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
35:24
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
At the Limits - Leading Medical Education
Рет қаралды 31 М.
Prof. Robert Lustig - 'Sugar, metabolic syndrome, and cancer'
57:42
Prof. Robert Lustig - 'Sugar, metabolic syndrome, and cancer'
Low Carb Down Under
Рет қаралды 1 МЛН
Free CME Opportunity! Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of CKD
52:59
Free CME Opportunity! Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of CKD
ACOIorg
Рет қаралды 92
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Management
7:05
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Management
KDIGO
Рет қаралды 4,7 М.
Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'
26:43
Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'
At the Limits - Leading Medical Education
Рет қаралды 2,1 М.
Emerging data from EMPA-KIDNEY study
57:22
Emerging data from EMPA-KIDNEY study
ERA - European Renal Association
Рет қаралды 2,7 М.
Debate a new era in the management of type 2 diabetes & cardiorenal disease
28:18
Debate a new era in the management of type 2 diabetes & cardiorenal disease
At the Limits - Leading Medical Education
Рет қаралды 713
Progress in the Care of Patients with PKD (17 Nov 2023) | Dr. Matt Lanktree | 2023 PKD Summit
59:25
Progress in the Care of Patients with PKD (17 Nov 2023) | Dr. Matt Lanktree | 2023 PKD Summit
PKD Foundation of Canada
Рет қаралды 270
Professor Peter Stenvinkel
33:58
Professor Peter Stenvinkel
At the Limits - Leading Medical Education
Рет қаралды 548
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
DO$HIK
Рет қаралды 3,3 МЛН